Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.06%
1,108.85
+0.62
+0.06%
—1,108.231,109.651,115.881,105.59——
SIXC
Communications
SIXC
Communications
SIXC
+0.92%
611.23
+5.60
+0.92%
—605.63605.63611.67602.96——
SIXE
Energy
SIXE
Energy
SIXE
-0.03%
1,209.57
-0.38
-0.03%
—1,209.951,210.981,211.681,197.20——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.31%
1,752.83
-5.40
-0.31%
—1,758.231,759.031,760.641,739.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.87%
629.40
-5.54
-0.87%
—634.94632.49632.49627.63——
SIXR
Staples
SIXR
Staples
SIXR
+0.21%
854.20
+1.83
+0.21%
—852.37850.81859.97849.13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.90%
216.88
-1.97
-0.90%
—218.85218.85218.85215.61——
SIXT
Technology
SIXT
Technology
SIXT
+1.20%
3,570.92
+42.43
+1.20%
—3,528.493,565.203,578.773,509.18——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.04%
905.30
-9.52
-1.04%
—914.82910.36910.36897.78——
SIXV
Health care
SIXV
Health care
SIXV
+0.72%
1,482.83
+10.56
+0.72%
—1,472.271,470.891,484.151,466.47——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.54%
2,403.57
+12.96
+0.54%
—2,390.612,387.312,409.702,373.97——
PHS:FRA
Photocure ASA
€5.77
+0.70%
(+0.040) 1D
May 13, 8:04:42 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHS...
Open
€5.77
High
€5.77
Low
€5.77
Avg. vol.
5.00
Volume
0.00
52-wk high
€6.71
52-wk low
€4.18
No. of employees
101
News stories
From sources across the web
Profile
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
About Photocure ASA
CEO-
Employees101
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
135.62M
134.96M
136.67M
264.61M
Cost of goods sold
10.04M
11.89M
10.93M
10.35M
Cost of revenue
10.04M
11.89M
10.93M
10.35M
Research and development expenses
506.00K
-862.00K
-415.00K
529.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
89.01M
93.60M
103.93M
99.59M
Operating expense
118.12M
120.69M
131.25M
133.58M
Total operating expenses
128.16M
132.57M
142.18M
143.93M
Operating income
7.46M
2.39M
-5.51M
120.68M
Other non operating income
-
-
-338.00K
9.41M
EBT including unusual items
2.51M
-398.00K
-9.42M
109.42M
EBT excluding unusual items
2.51M
-398.00K
-9.42M
109.42M
Income tax expense
-2.35M
-4.38M
-1.47M
26.00M
Effective tax rate
-93.55%
1,100.75%
15.57%
23.76%
Other operating expenses
28.60M
27.95M
27.74M
33.46M
Net income
4.86M
3.98M
-7.95M
83.42M
Net profit margin
3.59%
2.95%
-5.82%
31.53%
Earnings per share
-
0.15
-0.30
-
Interest and investment income
4.97M
4.22M
1.76M
-
Interest expense
-9.91M
-7.50M
-2.15M
-20.67M
Net interest expenses
-4.94M
-3.28M
-397.00K
-20.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.76M
9.72M
644.00K
128.32M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more